Open access
Aug 2026
Interleukin-15-armored ALPPL2 CAR T cells demonstrate robust preclinical efficacy for solid tumors
Chimeric antigen receptor (CAR) T therapy
Junquan Liu, Ning-Yan Zhang, Zhi-Qiang An et al.
· Molecular therapy. Oncology · 0 citations